🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 65 of 173

  1. US 10188704

    Enhanced melanoma cancer prevention by novel melanotropins

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10188461

    Selective fat removal using photothermal heating

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10189952

    Degradable thiol-ene polymers

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10188633

    Identification of small molecules that facilitate therapeutic exon skipping

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10183011

    Anti-depression compounds

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10183972

    BK channel-modulating peptides and their use

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10183055

    Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10182997

    Liposomal curcumin for treatment of cancer

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10182984

    Targeted interferons demonstrate potent apoptotic and anti-tumor activities

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10182979

    Biodegradable microspheres

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10183033

    Triptolide prodrugs

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10179112

    Viral vector nanocapsule for targeting gene therapy and its preparation

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10179187

    Bioresorbable embolization microspheres

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10179142

    Treatment and/or prevention of bone metastasis

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10179173

    Semi-solid delivery systems

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10173074

    Cancer stem cell vaccination and treatment

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10172920

    Sleep apnea treatment

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10175170

    Metal coating of rare earth nano-phosphors and uses thereof

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10174077

    Method of inhibiting activity of cell surface fibroblast activation protein alpha

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10174041

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10173980

    Mixed disulfide conjugates of thienopyridine compounds and uses thereof

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10172976

    Muscle cell patches and uses therefor

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10172938

    Multimode degradable hydrogels for controlled release of cargo substances

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10172908

    Method for treating cognitive dysfunction

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10172880

    Talen-based gene correction

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10172844

    Use of CDK9 inhibitors to reduce cartilage degradation

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10172831

    Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10172827

    Pro-neurogenic compounds

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10167337

    Combination immunotherapy for the treatment of cancer

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10166304

    Antibody fragments for detecting cancer and methods of use

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10168337

    Method and biomarkers for the detection of dengue hemorrhagic fever

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10167334

    Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10167295

    Analgesic compounds and methods of use

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10167259

    Allosteric inhibitors of proteasome and methods of use thereof

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10166271

    Methods for promoting hair growth

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10165788

    Methods and compositions for improved digestion of milk oligosaccharides

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10160954

    Engineered physical alignment of stem cell-derived cardiomyocytes

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10160962

    Purification of cystathionine beta-synthase

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10160769

    Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10159765

    Tissue engineered devices and methods for making same

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10159680

    Compositions comprising acidic extracts of mastic gum

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10155796

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10154970

    Methods for immunomodulation of cancer and infectious disease therapy

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10155798

    Anti-obesity compounds derived from neuromedin U

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10155789

    Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10155020

    Compositions and methods for treating hepatitis B

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10155014

    Cyclic di-AMP induction of type I interferon

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10154992

    Compounds and methods for treating HIV infection

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.